GlassScriptPhysician profile
Anthony John Suda
NPI 1750063186
$1,725.78
in general payments reported to CMS, 2019-2025
8 companies · $781 in 2025
The $781 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $375 · 2024: $570 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.79 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $583.20 | 2023-2025 | Jaypirca |
| Jazz Pharmaceuticals INC. | $275.38 | 2024-2025 | |
| Genmab U.S., INC. | $245.83 | 2024-2025 | Epkinly |
| Incyte Corporation | $226.00 | 2025 | Monjuvi, Monjuvi, Zynyz |
| Seagen INC. | $125.00 | 2023 | Adcetris |
| Pharmacyclics LLC, An Abbvie Company | $125.00 | 2023 | Epkinly |
| Pfizer INC. | $116.42 | 2024 | |
| Secura Bio, INC. | $28.95 | 2025 | Copiktra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Suda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.